| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 15710 |
| 1 | ADALIMUMAB | 7731 |
| 2 | PREDNISONE | 7705 |
| 3 | MESALAMINE | 6827 |
| 4 | INFLIXIMAB | 6235 |
| 5 | ISOTRETINOIN | 3809 |
| 6 | AZATHIOPRINE | 2668 |
| 7 | ERGOCALCIFEROL | 2132 |
| 8 | METHOTREXATE SODIUM | 1991 |
| 9 | METHOTREXATE | 1851 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRAHYDROZOLINE HYDROCHLORIDE | 86 | 0.2925 |
| 1 | INFLIXIMAB-DYYB | 899 | 0.2609 |
| 2 | MESALAMINE | 6827 | 0.2420 |
| 3 | VEDOLIZUMAB | 15710 | 0.1809 |
| 4 | MIRIKIZUMAB-MRKZ | 155 | 0.1717 |
| 5 | EPINEPHRINE HYDROCHLORIDE | 81 | 0.1709 |
| 6 | CUPRIC OXIDE | 65 | 0.1467 |
| 7 | USTEKINUMAB-AUUB | 21 | 0.1200 |
| 8 | OLSALAZINE SODIUM | 19 | 0.0964 |
| 9 | DIMETHYL SULFOXIDE | 23 | 0.0947 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 15796 |
| 1 | Corticosteroid [EPC] | 10691 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 9112 |
| 3 | Aminosalicylate [EPC] | 7499 |
| 4 | Retinoid [EPC] | 3851 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3005 |
| 6 | Purine Antimetabolite [EPC] | 2676 |
| 7 | Interleukin-23 Antagonist [EPC] | 2146 |
| 8 | Provitamin D2 Compound [EPC] | 2132 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 1866 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 126 | 0.1831 |
| 1 | Integrin Receptor Antagonist [EPC] | 15796 | 0.1814 |
| 2 | Endoglycosidase [EPC] | 161 | 0.0869 |
| 3 | Aminosalicylate [EPC] | 7499 | 0.0744 |
| 4 | Provitamin D2 Compound [EPC] | 2132 | 0.0716 |
| 5 | Nitrogen Binding Agent [EPC] | 153 | 0.0633 |
| 6 | Anthelmintic [EPC] | 162 | 0.0557 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 239 | 0.0274 |
| 8 | Purine Antimetabolite [EPC] | 2676 | 0.0271 |
| 9 | Interleukin-17A Antagonist [EPC] | 959 | 0.0257 |